Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment	eye disorder, proliferative vitreoretinopathy, retinal disorder	Not yet recruiting	Phase 2	2025-03-06		NCT06818721

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Unity Health Toronto	104

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
St. Michael's Hospital	Toronto	Canada	16
Sunnybrook Health Sciences Centre	Toronto	Canada	23

Clinical trials